Search results
Showing results for
NIHR Health Technology Aassessment is funding a new study looking at the risks and benefits of first line osteoporosis medications (oral bisphosphonates) amongst patients suffering from chronic kidney disease, led by Associate Professor Daniel Prieto-Alhambra of NDORMS.
Methods for the development and validation of computable phenotypes based on biobanks and linked real world data
Deadline - Friday 27 February 2026